Shinzato Takahiro, Kubo Taro, Shimizu Toshihiro, Nanmoku Koji, Yagisawa Takashi
Department of Renal Surgery and Transplantation, Jichi Medical University Hospital, 3311-1 Yakushiji, Shimotsuke, Tochigi, 3290498, Japan.
CEN Case Rep. 2019 May;8(2):79-82. doi: 10.1007/s13730-018-0369-3. Epub 2018 Oct 16.
We report a 55-year-old man with a renal allograft that developed sarcoidosis. His autosomal dominant polycystic kidney disease (ADPKD) progressed to end-stage stage renal disease when he was 52 years old, and he underwent living-donor kidney transplantation at the age of 53 years. His proteinuria worsened at 19 months post-transplantation, and his renal function began to decline at 29 months post-transplantation. A renal allograft biopsy performed at 31 months post-transplantation revealed non-caseating granulomatous interstitial nephritis. The patient was treated with prednisolone (0.5 mg/kg/day), with gradual reduction in the dose. His proteinuria improved and renal function did not deteriorate any further. To the best of our knowledge, this is the first case of sarcoidosis in a renal allograft recipient whose primary renal disease was ADPKD.
我们报告了一名55岁患有肾移植后发生结节病的男性患者。他的常染色体显性多囊肾病(ADPKD)在52岁时进展为终末期肾病,并于53岁时接受了活体供肾移植。移植后19个月时他的蛋白尿加重,移植后29个月时肾功能开始下降。移植后31个月进行的移植肾活检显示为非干酪样肉芽肿性间质性肾炎。患者接受泼尼松龙治疗(0.5mg/kg/天),并逐渐减量。他的蛋白尿得到改善,肾功能未进一步恶化。据我们所知,这是首例原发性肾病为ADPKD的肾移植受者发生结节病的病例。